ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Chronic Renal Insufficiency
Kidney Diseases
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Los Angeles, CA, USA:

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...

Enrolling
Chronic Kidney Disease
Secondary Hyperparathyroidism
Other: Standard of Care
Drug: Etelcalcetide

Phase 3

Amgen
Amgen

Los Angeles, California, United States and 43 other locations

Locations recently updated

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: ABBV-CLS-628
Drug: Placebo

Phase 2

Calico Life Sciences
Calico Life Sciences

Los Angeles, California, United States and 91 other locations

drugs"). The study is focused on participants who have diabetic kidney disease.The aim of the study is to see how safe and effectiv...

Enrolling
Diabetic Kidney Disease (DKD)
Drug: Evinacumab
Drug: ALN-ANG3 placebo

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Los Angeles, California, United States of America and 58 other locations

The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...

Enrolling
APOL1-Mediated Kidney Disease
Combination Product: AZD2373-Arm 2
Device: APOL1 Genotyping Clinical Trial Assay

Phase 2

AstraZeneca
AstraZeneca

Los Angeles, California, United States and 88 other locations

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

Phase 2, Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Los Angeles, California, United States and 330 other locations

Additionally, the study investigates the non-interventional feasibility of home measurement of serum creatinine in participants with diabetic kidney...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: AZD4248

Phase 1

AstraZeneca
AstraZeneca

Glendale, California, United States and 5 other locations

The purpose of this study is to determine whether vonsetamig will safely decrease anti-HLA antibodies to allow for kidney transplantation.Vo...

Active, not recruiting
Chronic Kidney Disease (CKD)
Drug: Vonsetamig

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Los Angeles, California, United States of America and 9 other locations

Locations recently updated

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...

Active, not recruiting
Chronic Kidney Disease
Drug: Vicadrostat
Drug: Empagliflozin

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Los Angeles, California, United States of America and 159 other locations

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Active, not recruiting
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Los Angeles, California, United States and 297 other locations

Locations recently updated

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Los Angeles, California, United States and 103 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems